The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide
2012-01-01 Forte, F.; Pizzoferrato, M.; Lopetuso, L.; Scaldaferri, F.
13C-octanoic acid breath test to study gastric emptying time
2013-01-01 Bruno, G.; Lopetuso, L. R.; Ianiro, G.; Laterza, L.; Gerardi, V.; Petito, V.; Poscia, A.; Gasbarrini, A.; Ojetti, V.; Scaldaferri, F.
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
2018-01-01 Lopetuso, L. R.; De Salvo, C.; Pastorelli, L.; Rana, N.; Senkfor, H. N.; Petito, V.; Di Martino, L.; Scaldaferri, F.; Gasbarrini, A.; Cominelli, F.; Abbott, D. W.; Goodman, W. A.; Pizarro, T. T.
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey
2024-01-01 Marasco, G.; Bruni, A.; Nardone, O. M.; Lopetuso, L. R.
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals
2018-01-01 Gibiino, G.; Lopetuso, L. R.; Scaldaferri, F.; Rizzatti, G.; Binda, C.; Gasbarrini, A.
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations
2019-01-01 Minordi, L. M.; Larosa, L.; Papa, A.; Bordonaro, V.; Lopetuso, L.; Holleran, G.; Gasbarrini, A.; Manfredi, R.
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment
2020-01-01 Lopetuso, L. R.; Corbi, M.; Scaldaferri, F.; Petito, V.; Graziani, C.; Castri, F.; Neri, M.; Gasbarrini, A.; Sgambato, A.; Papa, A.
Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature
2020-01-01 Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A.; Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A.
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk
2024-01-01 Di Mattia, Miriam; Sallese, Michele; Neri, Matteo; Lopetuso, Loris Riccardo
Coeliac disease under a microscope: Histological diagnostic features and confounding factors
2019-01-01 Gibiino, G.; Lopetuso, L.; Ricci, R.; Gasbarrini, A.; Cammarota, G.
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
2017-01-01 Scaldaferri, F.; D‘ambrosio, D.; Holleran, G.; Poscia, A.; Petito, V.; Lopetuso, L.; Graziani, C.; Laterza, L.; Pistone, M. T.; Pecere, S.; Currò, D.; Gaetani, E.; Armuzzi, A.; Papa, A.; Cammarota, G.; Gasbarrini, A.
Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease
2020-01-01 Lopetuso, L. R.; Gasbarrini, A.
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
2020-01-01 Scaldaferri, Franco; Ianiro, Gianluca; Privitera, Giuseppe; Lopetuso, Loris Riccardo; Vetrone, Lorenzo Maria; Petito, Valentina; Pugliese, Daniela; Neri, Matteo; Cammarota, Giovanni; Ringel, Yehuda; Costamagna, Guido; Gasbarrini, Antonio; Boskoski, Ivo; Armuzzi, Alessandro
Radiomics could predict surgery at 10 years in Crohn's disease
2023-01-01 Laterza, L.; Boldrini, L.; Tran, H. E.; Votta, C.; Larosa, L.; Minordi, L. M.; Maresca, R.; Pugliese, D.; Zocco, M. A.; Ainora, M. E.; Lopetuso, L. R.; Papa, A.; Armuzzi, A.; Gasbarrini, A.; Scaldaferri, F.
Development and Validation of Predictive Assessment of Complicated Diverticulitis Score
2021-01-01 Covino, M.; Papa, V.; Tursi, A.; Simeoni, B.; Lopetuso, L. R.; Vetrone, L. M.; Franceschi, F.; Rapaccini, G.; Gasbarrini, A.; Papa, A.
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
2021-01-01 Privitera, G.; Pugliese, D.; Lopetuso, L. R.; Scaldaferri, F.; Papa, A.; Rapaccini, G. L.; Gasbarrini, A.; Armuzzi, A.
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders
2019-01-01 Macchione, I. G.; Lopetuso, L. R.; Ianiro, G.; Napol, M.; Gibiino, G.; Rizzatt, G.; Petito, V.; Gasbarrini, A.; Scaldaferri, F.
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
2022-01-01 Papa, A.; Scaldaferri, F.; Covino, M.; Tursi, A.; Furfaro, F.; Mocci, G.; Lopetuso, L. R.; Maconi, G.; Bibbo, S.; Fiorani, M.; Laterza, L.; Mignini, I.; Napolitano, D.; Parisio, L.; Pizzoferrato, M.; Privitera, G.; Pugliese, D.; Schepis, T.; Schiavoni, E.; Settanni, C. R.; Vetrone, L. M.; Armuzzi, A.; Danese, S.; Gasbarrini, A.
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment
2020-01-01 Ponziani, F. R.; Scaldaferri, F.; De Siena, M.; Mangiola, F.; Matteo, M. V.; Pecere, S.; Petito, V.; Paroni Sterbini, F.; Lopetuso, L. R.; Masucci, L.; Cammarota, G.; Sanguinetti, M.; Gasbarrini, A.
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders
2017-01-01 Lopetuso, L. R.; Petito, V.; Graziani, C.; Schiavoni, E.; Paroni Sterbini, F.; Poscia, A.; Gaetani, E.; Franceschi, F.; Cammarota, G.; Sanguinetti, M.; Masucci, L.; Scaldaferri, F.; Gasbarrini, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The use of anti-spasmodics in the treatment of irritable bowel syndrome: Focus on otilonium bromide | 1-gen-2012 | Forte, F.; Pizzoferrato, M.; Lopetuso, L.; Scaldaferri, F. | |
| 13C-octanoic acid breath test to study gastric emptying time | 1-gen-2013 | Bruno, G.; Lopetuso, L. R.; Ianiro, G.; Laterza, L.; Gerardi, V.; Petito, V.; Poscia, A.; Gasbarrini, A.; Ojetti, V.; Scaldaferri, F. | |
| IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair | 1-gen-2018 | Lopetuso, L. R.; De Salvo, C.; Pastorelli, L.; Rana, N.; Senkfor, H. N.; Petito, V.; Di Martino, L.; Scaldaferri, F.; Gasbarrini, A.; Cominelli, F.; Abbott, D. W.; Goodman, W. A.; Pizarro, T. T. | |
| Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey | 1-gen-2024 | Marasco, G.; Bruni, A.; Nardone, O. M.; Lopetuso, L. R. | |
| Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals | 1-gen-2018 | Gibiino, G.; Lopetuso, L. R.; Scaldaferri, F.; Rizzatti, G.; Binda, C.; Gasbarrini, A. | |
| Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations | 1-gen-2019 | Minordi, L. M.; Larosa, L.; Papa, A.; Bordonaro, V.; Lopetuso, L.; Holleran, G.; Gasbarrini, A.; Manfredi, R. | |
| Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment | 1-gen-2020 | Lopetuso, L. R.; Corbi, M.; Scaldaferri, F.; Petito, V.; Graziani, C.; Castri, F.; Neri, M.; Gasbarrini, A.; Sgambato, A.; Papa, A. | |
| Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: A case report and review of the literature | 1-gen-2020 | Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A.; Papa, V.; Giustiniani, M. C.; Lopetuso, L. R.; Papa, A. | |
| Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk | 1-gen-2024 | Di Mattia, Miriam; Sallese, Michele; Neri, Matteo; Lopetuso, Loris Riccardo | |
| Coeliac disease under a microscope: Histological diagnostic features and confounding factors | 1-gen-2019 | Gibiino, G.; Lopetuso, L.; Ricci, R.; Gasbarrini, A.; Cammarota, G. | |
| Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab | 1-gen-2017 | Scaldaferri, F.; D‘ambrosio, D.; Holleran, G.; Poscia, A.; Petito, V.; Lopetuso, L.; Graziani, C.; Laterza, L.; Pistone, M. T.; Pecere, S.; Currò, D.; Gaetani, E.; Armuzzi, A.; Papa, A.; Cammarota, G.; Gasbarrini, A. | |
| Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease | 1-gen-2020 | Lopetuso, L. R.; Gasbarrini, A. | |
| The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications | 1-gen-2020 | Scaldaferri, Franco; Ianiro, Gianluca; Privitera, Giuseppe; Lopetuso, Loris Riccardo; Vetrone, Lorenzo Maria; Petito, Valentina; Pugliese, Daniela; Neri, Matteo; Cammarota, Giovanni; Ringel, Yehuda; Costamagna, Guido; Gasbarrini, Antonio; Boskoski, Ivo; Armuzzi, Alessandro | |
| Radiomics could predict surgery at 10 years in Crohn's disease | 1-gen-2023 | Laterza, L.; Boldrini, L.; Tran, H. E.; Votta, C.; Larosa, L.; Minordi, L. M.; Maresca, R.; Pugliese, D.; Zocco, M. A.; Ainora, M. E.; Lopetuso, L. R.; Papa, A.; Armuzzi, A.; Gasbarrini, A.; Scaldaferri, F. | |
| Development and Validation of Predictive Assessment of Complicated Diverticulitis Score | 1-gen-2021 | Covino, M.; Papa, V.; Tursi, A.; Simeoni, B.; Lopetuso, L. R.; Vetrone, L. M.; Franceschi, F.; Rapaccini, G.; Gasbarrini, A.; Papa, A. | |
| Orphan patients with inflammatory bowel disease - when we treat beyond evidence | 1-gen-2021 | Privitera, G.; Pugliese, D.; Lopetuso, L. R.; Scaldaferri, F.; Papa, A.; Rapaccini, G. L.; Gasbarrini, A.; Armuzzi, A. | |
| Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders | 1-gen-2019 | Macchione, I. G.; Lopetuso, L. R.; Ianiro, G.; Napol, M.; Gibiino, G.; Rizzatt, G.; Petito, V.; Gasbarrini, A.; Scaldaferri, F. | |
| Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study | 1-gen-2022 | Papa, A.; Scaldaferri, F.; Covino, M.; Tursi, A.; Furfaro, F.; Mocci, G.; Lopetuso, L. R.; Maconi, G.; Bibbo, S.; Fiorani, M.; Laterza, L.; Mignini, I.; Napolitano, D.; Parisio, L.; Pizzoferrato, M.; Privitera, G.; Pugliese, D.; Schepis, T.; Schiavoni, E.; Settanni, C. R.; Vetrone, L. M.; Armuzzi, A.; Danese, S.; Gasbarrini, A. | |
| Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment | 1-gen-2020 | Ponziani, F. R.; Scaldaferri, F.; De Siena, M.; Mangiola, F.; Matteo, M. V.; Pecere, S.; Petito, V.; Paroni Sterbini, F.; Lopetuso, L. R.; Masucci, L.; Cammarota, G.; Sanguinetti, M.; Gasbarrini, A. | |
| Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders | 1-gen-2017 | Lopetuso, L. R.; Petito, V.; Graziani, C.; Schiavoni, E.; Paroni Sterbini, F.; Poscia, A.; Gaetani, E.; Franceschi, F.; Cammarota, G.; Sanguinetti, M.; Masucci, L.; Scaldaferri, F.; Gasbarrini, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista14314
- 3 Libro1
Data di pubblicazione
- In corso di stampa6
- 2020 - 20268401
- 2010 - 20194497
- 2000 - 20091129
- 1990 - 1999234
- 1980 - 198946
- 1979 - 19792
Editore
- Dykinson1
- Luigi Pellegrini Editore1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...293
- JOURNAL OF CLINICAL MEDICINE160
- CANCERS126
- SCIENTIFIC REPORTS122
- JOURNAL OF BIOLOGICAL REGULATORS ...112
- PLOS ONE112
- Q-TIMES WEBMAGAZINE112
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- APPLIED SCIENCES98
- JOURNAL OF PERSONALIZED MEDICINE80
Keyword
- Humans374
- COVID-19361
- SARS-CoV-2191
- Male170
- Female160
- Italy111
- Middle Aged103
- Adult90
- Aged88
- inflammation76
Lingua
- eng10403
- ita1601
- fre41
- spa26
- und12
- pol7
- ger5
- por5
- afr1
- enm1
Accesso al fulltext
- no fulltext14309
- reserved6